Advances in Breast Cancer Therapy (IBRP)
Abstract
Therapeutics, Inc. 1) wrote and gained approval for the data safety monitoring plan for this protocol; 2) identified and contracted a medical monitor for this protocol; 3) revised the protocol, informed consent and case report forms, and obtained approval by the USAMRMC ORP HRPO; 4) submitted the protocol and informed consent form to the Western IRB for approval; 5) is collaborating with Windber Research Institute in the preparation of the protocol for the gene chip analysis; 6) secured the vendor for the specimen kits; and negotiated a contract with vendor to provide the electronic data collection, management, and reporting system used for this protocol; and, 7) contracted a medical science liaison for the identification of qualified participating investigators and sites.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2008
- Accession Number
- ADA486762
Entities
People
- Holly Gallion